Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

WINGS-4-FGS · (W)Initiative for womeN and GirlS affected by Female Genital Schistosomiasis

HORIZONStatus: SIGNED1 June 202531 May 2029EU funding €5,036,365Call HORIZON-JU-GH-EDCTP3-2024-01-two-stage

WINGS-4-FGS addresses pressing needs for tackling Female Genital Schistosomiasis (FGS) in Africa, with the objective of improving case management and therapeutic access while integrating care into sexual and reproductive health strategies. FGS, a consequence of schistosomiasis caused by the parasite Schistosoma haematobium, affects millions of women and girls in sub-Saharan Africa, leading to significant morbidity and reproductive health issues. Current treatment barriers include limited knowledge, associated stigma, a lack of effective treatment, and inadequate diagnostic tools. WINGS-4-FGS proposes a multifaceted, holistic approach and aims to: i) investigate the efficacy of anti-inflammatory medications as add-ons to praziquantel; ii) implement training programs to increase awareness and medical care competency; iii) implement a community-based, two-step, self-sampling diagnostic strategy; iv) assess barriers and facilitators for integrating FGS into existing health services. WINGS-4-FGS aims to generate evidence-based recommendations, enhance local capacity, and engage stakeholders and policymakers to integrate FGS care into African countries’ healthcare systems effectively. Success will lead to improved treatment guidelines and practices that will enable patients and healthcare workers to recognize, diagnose, and treat the disease before symptoms spread, as well as foster affordable local access to treatment and reduce associated stigma. The transdisciplinary consortium brings together 11 renowned partners with expertise in tropical disease research, coming from 3 European (Germany, Switzerland and United Kingdom) and 6 African countries: Democratic Republic of Congo, Côte d’Ivoire and Malawi, where the clinical trials will be conducted, as well as Ghana, Madagascar and Rwanda. WINGS-4-FGS will forge sustainable solutions for future generations of women and girls so they can feel empowered to manage their own reproductive health and overall well-being.

Consortium · 11 organisations

coordinator

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER

UK · €885,169

participant

KAMUZU UNIVERSITY OF HEALTH SCIENCES

MW · €747,534

associatedPartner

Association pour la Promotion de la Santé de l'Intelligence Artificielle et du Numérique

MG

participant

EURICE EUROPEAN RESEARCH AND PROJECT OFFICE GMBH

DE · €520,625

participant

UNIVERSITY OF HEALTH AND ALLIED SCIENCES

GH · €730,375

participant

INSTITUT NATIONAL DE RECHERCHE BIOMEDICALE DU ZAIRE

CD · €709,875

participant

UNIVERSITE FELIX HOUPHOUET BOIGNY

CI · €701,465

associatedPartner

SCHWEIZERISCHES TROPEN UND PUBLIC HEALTH INSTITUT

CH

participant

AFRICAN PHARMACEUTICAL TECHNOLOGY FOUNDATION

RW · €38,750

participant

BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN

DE · €702,571

associatedPartner

DRUGS FOR NEGLECTED DISEASES INITIATIVE FONDATION

CH

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.